403 related articles for article (PubMed ID: 11171826)
41. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.
Lee SY; Miyai K; Han HS; Hwang DY; Seong MK; Chung H; Jung BH; Devaraj B; McGuire KL; Carethers JM
Dig Dis Sci; 2012 Jan; 57(1):72-8. PubMed ID: 21773681
[TBL] [Abstract][Full Text] [Related]
42. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
43. A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment.
Lea D; Watson M; Skaland I; Hagland HR; Lillesand M; Gudlaugsson E; Søreide K
Cancer Immunol Immunother; 2021 Jul; 70(7):2049-2057. PubMed ID: 33439293
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
[TBL] [Abstract][Full Text] [Related]
45. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis.
Biemer-Hüttmann AE; Walsh MD; McGuckin MA; Simms LA; Young J; Leggett BA; Jass JR
Clin Cancer Res; 2000 May; 6(5):1909-16. PubMed ID: 10815915
[TBL] [Abstract][Full Text] [Related]
46. Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.
Horimoto Y; Thinzar Hlaing M; Saeki H; Kitano S; Nakai K; Sasaki R; Kurisaki-Arakawa A; Arakawa A; Otsuji N; Matsuoka S; Tokuda E; Arai M; Saito M
Cancer Sci; 2020 Jul; 111(7):2647-2654. PubMed ID: 32449246
[TBL] [Abstract][Full Text] [Related]
47. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
[TBL] [Abstract][Full Text] [Related]
48. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
Shia J; Black D; Hummer AJ; Boyd J; Soslow RA
Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
[TBL] [Abstract][Full Text] [Related]
49. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
50. Low-level microsatellite instability colorectal carcinomas: do they really belong to a "gray zone" between high-level microsatellite instability and microsatellite-stable cancers?
Rudzki Z; Zazula M; Okoń K; Stachura J
Int J Colorectal Dis; 2003 May; 18(3):216-21. PubMed ID: 12673486
[TBL] [Abstract][Full Text] [Related]
51. Pathologic predictors of microsatellite instability in colorectal cancer.
Greenson JK; Huang SC; Herron C; Moreno V; Bonner JD; Tomsho LP; Ben-Izhak O; Cohen HI; Trougouboff P; Bejhar J; Sova Y; Pinchev M; Rennert G; Gruber SB
Am J Surg Pathol; 2009 Jan; 33(1):126-33. PubMed ID: 18830122
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic characteristics of colorectal cancer with microsatellite instability.
Ziadi S; Ksiaa F; Ben Gacem R; Labaied N; Mokni M; Trimeche M
Pathol Res Pract; 2014 Feb; 210(2):98-104. PubMed ID: 24286815
[TBL] [Abstract][Full Text] [Related]
53. CD169
Saito Y; Fujiwara Y; Miyamoto Y; Ohnishi K; Nakashima Y; Tabata Y; Baba H; Komohara Y
Cancer Med; 2023 May; 12(9):10199-10211. PubMed ID: 36846928
[TBL] [Abstract][Full Text] [Related]
54. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
[TBL] [Abstract][Full Text] [Related]
55. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
[TBL] [Abstract][Full Text] [Related]
56. Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer.
Drescher KM; Sharma P; Watson P; Gatalica Z; Thibodeau SN; Lynch HT
Fam Cancer; 2009; 8(3):231-9. PubMed ID: 19165625
[TBL] [Abstract][Full Text] [Related]
57. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
[TBL] [Abstract][Full Text] [Related]
58. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
[TBL] [Abstract][Full Text] [Related]
59. Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients.
Aasebø K; Bruun J; Bergsland CH; Nunes L; Eide GE; Pfeiffer P; Dahl O; Glimelius B; Lothe RA; Sorbye H
Br J Cancer; 2022 Jan; 126(1):48-56. PubMed ID: 34671130
[TBL] [Abstract][Full Text] [Related]
60. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.
Walsh MD; Dent OF; Young JP; Wright CM; Barker MA; Leggett BA; Bokey L; Chapuis PH; Jass JR; Macdonald GA
Int J Cancer; 2009 Sep; 125(5):1231-7. PubMed ID: 19462453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]